October 24, 2018 / 6:51 PM / 25 days ago

BRIEF-Eyevance Pharmaceuticals Acquires Flarex 0.1 Pct From Novartis AG

Oct 24 (Reuters) - Novartis AG:

* EYEVANCE PHARMACEUTICALS - ACQUIRED FLAREX 0.1% FROM NOVARTIS AG

* EYEVANCE PHARMACEUTICALS - ACQUIRES EXCLUSIVE RIGHTS FROM NOVARTIS AG TO COMMERCIALIZE FLAREX IN UNITED STATES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below